{
  "id": 7678272,
  "title": "Clover Health CEO, Medicare advantage, Jamie Reynoso sells $44,324 in CLOV shares",
  "url": "https://urgent.news/2026/09/16/clover-health-ceo-medicare-advantage-jamie-reynoso-sells-44-324-in",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-16T01:30:49.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/clover-health-ceo-medicare-advantage-jamie-reynoso-sells-44324-in-clov-shares-93CH-4902825"
  },
  "original_language": "en",
  "account": "Clover Health CEO Jamie Reynoso sold 9,273 shares of the company's Class A Common Stock for a total of $44,324 on September 15, 2026. The transaction occurred to satisfy tax withholding obligations related to the vesting of his restricted stock units. At the time of the sale, Clover Health's stock was trading at $4.66, up 137% over the past six months. Despite the stock being deemed overvalued by InvestingPro, Clover Health surpassed analysts' expectations for Q2 2026, reporting adjusted earnings of $0.05 per share and revenue of $743.2 million. The company has also raised its full-year guidance, signaling optimism for the future.",
  "summary": null,
  "key_points": [
    "Jamie Reynoso, Clover Health CEO, sold 9,273 shares on September 15, 2026.",
    "Sale totaled $44,324, at $4.66 per share, reflecting 137% stock increase.",
    "Clover Health exceeded Q2 2026 earnings expectations with $0.05 per share profit."
  ],
  "editors_take": "The CEO's sale of company shares to cover tax obligations does not appear to have dented investor confidence, with the stock up 137% in six months and the company raising its full-year guidance.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}